A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

A proposed cycle threshold value for viral abundance could help laboratories assess sample quality and potentially improve early variant detection ... “In response to the COVID-19 pandemic, NGS ...

while maintaining immunization protection against current and future COVID-19 variants and a benign tolerability profile. We thank BARDA for their strong leadership, partnership and funding to make ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality ... during future outbreaks of ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Meanwhile, COVID activity remained low amid a shift in variant proportions and RSV levels rose in 3 US regions.

The CDC said several factors are probably contributing to a post-pandemic rise in pertussis activity. Aside from waning ...

COVID-19 will continue to spread at different levels in our communities, and outbreaks will still occur. New variants of concern may also emerge. There's also uncertainty around how long immunity from ...

Since 2020, COVID-19 has surged across the nation and the world. With variants like Omicron, Delta, Alpha and more, this ...

Concerns about COVID-19 have significantly diminished, but researchers continue to analyze its high transmission rate, aiming ...

LTV is more effective than NTV and ETV against Mpro mutants, making it a promising candidate for treating drug-resistant ...